ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,440,000 | -13.0% | 1,000,000 | -4.3% | 7.33% | -2.1% |
| Q3 2016 | $14,306,000 | +54.9% | 1,045,000 | -16.4% | 7.49% | +21.3% |
| Q2 2016 | $9,238,000 | +15.6% | 1,250,000 | 0.0% | 6.17% | +23.9% |
| Q1 2016 | $7,988,000 | -2.4% | 1,250,000 | -4.6% | 4.98% | +45.5% |
| Q4 2015 | $8,188,000 | +7.0% | 1,310,000 | 0.0% | 3.42% | -9.1% |
| Q3 2015 | $7,650,000 | -38.3% | 1,310,000 | -12.7% | 3.76% | -23.7% |
| Q2 2015 | $12,405,000 | +0.4% | 1,500,000 | 0.0% | 4.94% | -14.0% |
| Q1 2015 | $12,360,000 | +18.0% | 1,500,000 | -1.6% | 5.74% | +8.4% |
| Q4 2014 | $10,477,000 | -99.9% | 1,525,000 | +1.7% | 5.29% | -16.2% |
| Q3 2014 | $8,100,000,000 | +76503.0% | 1,500,000 | -9.6% | 6.31% | -30.7% |
| Q2 2014 | $10,574,000 | -21.4% | 1,660,000 | -0.6% | 9.12% | -8.3% |
| Q1 2014 | $13,460,000 | -99.9% | 1,670,000 | 0.0% | 9.94% | +6.8% |
| Q4 2013 | $11,857,000,000 | – | 1,670,000 | – | 9.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |